Literature DB >> 20576632

Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge.

A Butterly1, E A Bittner, E George, W S Sandberg, M Eikermann, U Schmidt.   

Abstract

BACKGROUND: Postoperative residual curarization (PORC) [train-of-four ratio (T4/T1) <0.9] is associated with increased morbidity and may delay postoperative recovery room (PACU) discharge. We tested the hypothesis that postoperative T4/T1 <0.9 increases PACU length of stay.
METHODS: At admission to the PACU, neuromuscular transmission was assessed by acceleromyography (stimulation current: 30 mA) in 246 consecutive patients. The potential consequences of PORC-induced increases in PACU length of stay on PACU throughput were estimated by application of a validated queuing model taking into account the rate of PACU admissions and mean length of stay in the joint system of the PACU plus patients recovering in operation theatre waiting for PACU beds.
RESULTS: PACU length of stay was significantly longer in patients with T4/T1 <0.9 (323 min), compared with patients with adequate recovery of neuromuscular transmission (243 min). Age (P=0.021) and diagnosis of T4/T1 <0.9 (P=0.027), but not the type of neuromuscular blocking agent, were independently associated with PACU length of stay. The incidence of T4/T1 <0.9 was higher in patients receiving vecuronium. Delayed discharge significantly increases the chances of patients having to wait to enter the PACU. The presence of PORC is estimated to be associated with significant delays in recovery room admission.
CONCLUSIONS: PORC is associated with a delayed PACU discharge. The magnitude of the effect is clinically significant. In our system, PORC increases the chances of patients having to wait to enter the PACU.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576632     DOI: 10.1093/bja/aeq157

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  37 in total

Review 1.  Anesthesia and fast-track in video-assisted thoracic surgery (VATS): from evidence to practice.

Authors:  Marzia Umari; Stefano Falini; Matteo Segat; Michele Zuliani; Marco Crisman; Lucia Comuzzi; Francesco Pagos; Stefano Lovadina; Umberto Lucangelo
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Neuromuscular blockade improves surgical conditions (NISCO).

Authors:  Manfred Blobner; Christiane G Frick; Roland B Stäuble; Hubertus Feussner; Stefan J Schaller; Christoph Unterbuchner; Charlotte Lingg; Martina Geisler; Heidrun Fink
Journal:  Surg Endosc       Date:  2014-08-15       Impact factor: 4.584

Review 3.  Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations.

Authors:  A Thorell; A D MacCormick; S Awad; N Reynolds; D Roulin; N Demartines; M Vignaud; A Alvarez; P M Singh; D N Lobo
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

4.  Anesthesia and analgesia: how does the role of anesthetists changes in the ERAS program for VATS lobectomy.

Authors:  Federico Piccioni; Riccardo Ragazzi
Journal:  J Vis Surg       Date:  2018-01-11

5.  Longer Immediate Recovery Time After Anesthesia Increases Risk of Respiratory Complications After Laparotomy for Bariatric Surgery: a Randomized Clinical Trial and a Cohort Study.

Authors:  Eliana C M Sudré; Priscila R de Batista; Yara M M Castiglia
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

6.  Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?

Authors:  Hassan Farhan; Ingrid Moreno-Duarte; Duncan McLean; Matthias Eikermann
Journal:  Curr Anesthesiol Rep       Date:  2014-12

7.  Sugammadex allows fast-track bariatric surgery.

Authors:  Michele Carron; Stefano Veronese; Mirto Foletto; Carlo Ori
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

8.  A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.

Authors:  Yiling Jiang; Lori D Bash; Leif Saager
Journal:  Adv Ther       Date:  2021-04-19       Impact factor: 3.845

9.  In Vitro selectivity of an acyclic cucurbit[n]uril molecular container towards neuromuscular blocking agents relative to commonly used drugs.

Authors:  Shweta Ganapati; Peter Y Zavalij; Matthias Eikermann; Lyle Isaacs
Journal:  Org Biomol Chem       Date:  2015-12-09       Impact factor: 3.876

10.  Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.

Authors:  Martina Grosse-Sundrup; Justin P Henneman; Warren S Sandberg; Brian T Bateman; Jose Villa Uribe; Nicole Thuy Nguyen; Jesse M Ehrenfeld; Elizabeth A Martinez; Tobias Kurth; Matthias Eikermann
Journal:  BMJ       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.